Tipsheet
What matters at India’s listed companies
Earnings · Pharmaceuticals · Small cap

Venus Remedies reports audited results and declares dividend

The company confirmed its previously disclosed annual figures and recommended a final dividend of ₹10 per share.

2 earlier stories on Venus Remedies Ltd.
Mkt cap₹1,551 cr
P/E20.34×
ROE8.08%
Debt / eq.0.00
₹102.8 cr Consolidated net profit for FY26.

What's new

  • Board confirmed audited FY26 results with a consolidated net profit of ₹102.8 cr.
  • Standalone net profit for the year is ₹99.3 cr.
  • Directors were reappointed and new articles of association were adopted.

Why this matters

This filing contains no new information for investors. The financial performance and dividend payout were already public knowledge, and the governance updates are standard procedural requirements.

What we're watching

  • Any future updates on the company's long-term growth strategy.
  • The official record date for the dividend payment.
  • Operational performance in the upcoming fiscal year.

The full read

Venus Remedies has finalized its audited financial results for FY26, reporting a consolidated net profit of ₹102.8 crore and a standalone net profit of ₹99.3 crore. The board also confirmed a final dividend recommendation of ₹10 per share.

It adds nothing new.

These figures were already public, as were the governance updates regarding director reappointments and the adoption of new articles of association, meaning this filing is merely a routine procedural step that confirms previously disclosed performance without offering any fresh insight for shareholders to consider as they evaluate the company's long-term trajectory.

Questions answered

What is the final dividend amount?
The board has recommended a final dividend of ₹10 per share.
How did the company perform in FY26?
Venus Remedies reported a consolidated net profit of ₹102.8 crore and a standalone net profit of ₹99.3 crore.
Does this filing contain any new financial surprises?
No. The figures and dividend recommendation were already disclosed in previous filings.
Are there any significant governance changes?
The company completed routine reappointments of directors and adopted new memorandum and articles of association.
Mentioned: Venus Remedies Ltd.
Primary source BSE · NSE · Tijori

An independent reading of the company's own disclosure — the primary filing above is the final word.

  1. 26 May 2026 · 10:10 PM IST Venus Remedies reports audited results and declares dividend
  2. today Venus Remedies posts 89% profit jump and names new board members
  3. today Venus Remedies profit jumps 89% as annual revenue hits ₹768.7 cr